Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
OBJECTIVE: To study the follow-up of men with elevated prostate-specific antigen (PSA) (>3 ng/ml) after one benign set of sextant biopsies. From the Göteborg branch of the European Randomised Study of Screening for Prostate Cancer (ERSPC). METHOD: 456 men with one set of benign sextant biops...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2003
|
| _version_ | 1797069625246089216 |
|---|---|
| author | Zackrisson, B Aus, G Lilja, H Lodding, P Pihl, C Hugosson, J |
| author_facet | Zackrisson, B Aus, G Lilja, H Lodding, P Pihl, C Hugosson, J |
| author_sort | Zackrisson, B |
| collection | OXFORD |
| description | OBJECTIVE: To study the follow-up of men with elevated prostate-specific antigen (PSA) (>3 ng/ml) after one benign set of sextant biopsies. From the Göteborg branch of the European Randomised Study of Screening for Prostate Cancer (ERSPC). METHOD: 456 men with one set of benign sextant biopsies were followed every second year for 4 years with PSA determinations. In cases of elevated PSA, transrectal ultrasound (TRUS) guided sextant biopsies were suggested. Digital rectal examination (DRE), prostate volume, PSA, PSA density (PSAD) and the ratio between free and total PSA (PSA F/T) were recorded. RESULTS: Complete data were available for 322 men. 3 groups were identified. In 84/322 (26%) men cancer was found ("cancer" group). 182/322 (56%) had benign biopsies ("benign" group) and 56/322 (17%) had normalised PSA ("normalised PSA" group). Median prostate volumes were 36, 46, and 33 cc respectively in the three groups. DRE and/or TRUS were abnormal in only 30% of the men in all groups. Cancer was not found in any prostate >70 cc volume. In prostates of <20 cc either cancer was found or PSA was normalised. The "normalised PSA" group had initial PSA, PSAD and PSA F/T similar to cancer, normalising during follow-up. CONCLUSIONS: Patients with one negative sextant biopsy still have a high likelihood of cancer, especially men with persistently elevated PSA and small prostates (<20 cc) while the majority of men with large prostates (>70 cc) have PSA elevation due to benign prostate hyperplasia (BPH) and not to cancer. |
| first_indexed | 2024-03-06T22:27:14Z |
| format | Journal article |
| id | oxford-uuid:57113d78-d275-4395-92b8-28b14b6f2f1d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:27:14Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:57113d78-d275-4395-92b8-28b14b6f2f1d2022-03-26T16:54:22ZFollow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:57113d78-d275-4395-92b8-28b14b6f2f1dEnglishSymplectic Elements at Oxford2003Zackrisson, BAus, GLilja, HLodding, PPihl, CHugosson, J OBJECTIVE: To study the follow-up of men with elevated prostate-specific antigen (PSA) (>3 ng/ml) after one benign set of sextant biopsies. From the Göteborg branch of the European Randomised Study of Screening for Prostate Cancer (ERSPC). METHOD: 456 men with one set of benign sextant biopsies were followed every second year for 4 years with PSA determinations. In cases of elevated PSA, transrectal ultrasound (TRUS) guided sextant biopsies were suggested. Digital rectal examination (DRE), prostate volume, PSA, PSA density (PSAD) and the ratio between free and total PSA (PSA F/T) were recorded. RESULTS: Complete data were available for 322 men. 3 groups were identified. In 84/322 (26%) men cancer was found ("cancer" group). 182/322 (56%) had benign biopsies ("benign" group) and 56/322 (17%) had normalised PSA ("normalised PSA" group). Median prostate volumes were 36, 46, and 33 cc respectively in the three groups. DRE and/or TRUS were abnormal in only 30% of the men in all groups. Cancer was not found in any prostate >70 cc volume. In prostates of <20 cc either cancer was found or PSA was normalised. The "normalised PSA" group had initial PSA, PSAD and PSA F/T similar to cancer, normalising during follow-up. CONCLUSIONS: Patients with one negative sextant biopsy still have a high likelihood of cancer, especially men with persistently elevated PSA and small prostates (<20 cc) while the majority of men with large prostates (>70 cc) have PSA elevation due to benign prostate hyperplasia (BPH) and not to cancer. |
| spellingShingle | Zackrisson, B Aus, G Lilja, H Lodding, P Pihl, C Hugosson, J Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. |
| title | Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. |
| title_full | Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. |
| title_fullStr | Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. |
| title_full_unstemmed | Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. |
| title_short | Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. |
| title_sort | follow up of men with elevated prostate specific antigen and one set of benign biopsies at prostate cancer screening |
| work_keys_str_mv | AT zackrissonb followupofmenwithelevatedprostatespecificantigenandonesetofbenignbiopsiesatprostatecancerscreening AT ausg followupofmenwithelevatedprostatespecificantigenandonesetofbenignbiopsiesatprostatecancerscreening AT liljah followupofmenwithelevatedprostatespecificantigenandonesetofbenignbiopsiesatprostatecancerscreening AT loddingp followupofmenwithelevatedprostatespecificantigenandonesetofbenignbiopsiesatprostatecancerscreening AT pihlc followupofmenwithelevatedprostatespecificantigenandonesetofbenignbiopsiesatprostatecancerscreening AT hugossonj followupofmenwithelevatedprostatespecificantigenandonesetofbenignbiopsiesatprostatecancerscreening |